Macrodomain is a relatively small protein fold consisting of ~150 amino acids which has been identified in humans and pathogens, including all coronaviruses. Most macrodomains bind to the small molecule ADP-ribose and ADP-ribosylated proteins. Recent data revealed that a subset of macrodomain in humans and viruses possesses enzymatic activity to hydrolyze ADP-ribose from ADP-ribosylated proteins. For example, these enzymatically active macrodomains are present in a subset of positive-stranded RNA viruses, including coronaviruses, alphaviruses, rubella virus, and hepatitis E virus.
The ability to bind and remove ADP-ribose is critical for viral replication and virulence, making macrodomain an attractive antiviral target.
Dasovich M, Zhuo J, Goodman JA, Thomas A, McPherson RL, Jayabalan AK, Busa VF, Cheng SJ, Murphy BA, Redinger KR, Alhammad YMO, Fehr AR, Tsukamoto T, Slusher BS, Bosch J, Wei H, Leung AKL. High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain. ACS Chem Biol. 2021 Dec 14 [Abstract/PDF]
McPherson RL, Abraham R, Sreekumar E, Ong SE, Cheng SJ, Baxter VK, Kistemaker HA, Filippov DV, Griffin DE, Leung AK. ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulence. Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1666-1671. [Abstract/PDF]
Leung AKL, McPherson RL, Griffin DE. Macrodomain ADP-ribosylhydrolase and the pathogenesis of infectious diseases. PLoS Pathog. 2018 Mar 22;14(3):e1006864. [Abstract/PDF]